Transaction · 0001437749-26-032240

Krempa David

Krempa David, CBO, reported an open-market or private sale at Eton Pharmaceuticals, Inc. involving 4166.000000 shares for an estimated $229406.21. Reported holdings after the transaction were 43381.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCBO
ETONEton Pharmaceuticals, Inc.
Filing timeOct 06
Trade dateOct 06, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded8.76%Shares sold ÷ (holdings after + shares sold). Estimated position before: 47,547 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$57.68
Pre-filing
1mo ago +1.3%1w ago +0.0%1d ago +0.0%
Returns since
7d30d90d180d1y

ETON price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ETON since 2026-10-06Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001437749-26-032240
Common Stock
Transaction date
Oct 06, 2026
Filed Oct 06, 2026, 08:49 PM · 0d delay
Shares
4.16k sh
$55.07 per share
Estimated value
-$229k
Computed from shares × price
Holdings after
43.3k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Business Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchase…

  2. F2

    The shares were sold in multiple trades at prices ranging from $54.915 to $55.135. The price reported above reflects the weighted average sales price.

  3. F3

    On October 2, 2024, the reporting person was granted 42,088 restricted stock units which vest in four equal annual installments beginning October 2, 2025.

Original filing · 0001437749-26-032240
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ETON